Identification of MIR-625-3P As Potential Blood-Based Biomarker for malignant Pleural Mesothelioma

M.B. Kirschner, Y.Y. Cheng, B. Badrian, S.C. Kao, Jenette Creaney, J.J.B. Edelman, N.J. Armstrong, M.P. Valley, Arthur Musk, Bruce Robinson, B.C. Mccaughan, S Klebe, Steve Mutsaers, N.V. Zandwijk, G Reid

Research output: Chapter in Book/Conference paperConference paper

Original languageEnglish
Title of host publicationMesothelioma Epidemiology 2012
Place of PublicationBoston
PublisherInternational Mesothelioma Interest Group
Pages68
Volumeonline
Publication statusPublished - 2012
EventIdentification of MIR-625-3P As Potential Blood-Based Biomarker for malignant Pleural Mesothelioma - Boston
Duration: 1 Jan 2012 → …

Conference

ConferenceIdentification of MIR-625-3P As Potential Blood-Based Biomarker for malignant Pleural Mesothelioma
Period1/01/12 → …

Cite this

Kirschner, M. B., Cheng, Y. Y., Badrian, B., Kao, S. C., Creaney, J., Edelman, J. J. B., Armstrong, N. J., Valley, M. P., Musk, A., Robinson, B., Mccaughan, B. C., Klebe, S., Mutsaers, S., Zandwijk, N. V., & Reid, G. (2012). Identification of MIR-625-3P As Potential Blood-Based Biomarker for malignant Pleural Mesothelioma. In Mesothelioma Epidemiology 2012 (Vol. online, pp. 68). International Mesothelioma Interest Group.